Insights

Gathering insights about Baxalta…

Similar companies to Baxalta

Baxalta Tech Stack

Media & News

The Shire merges with Baxalta Incorporated.
Even if some patients responded very well and the compound received breakthrough therapy designation, the interest in maralixibat faded when Shire merged with Baxalta.
Jan 27, 2024 | www.sdentrepreneurs.org
Takeda acquired Baxalta Incorporated on Jan 1st '19.
It is worth noting that Takeda acquired Baxalta through a series of merger transactions, with Shire initially incorporating Baxalta into its portfolio in 2016, followed by Takeda's acquisition of Shire in 2019.
Sep 21, 2023 | pharmtales.com
Baxalta Incorporated invests into assets: AAV8 vector.
Baxalta, through its then parent company Baxter ($BAX), acquired the AAV8 vector in the $70 million takeover of Chatham Therapeutics.
Oct 07, 2022 | www.fiercebiotech.com
Bayer AG files suit against Baxalta Incorporated.
After Baxalta developed a PEGylated FVIII therapeutic, Adynovate®, Bayer sued Baxalta for infringement of its patent.
Mar 11, 2021 | www.jdsupra.com
Baxalta Incorporated launched six clinical trials: NCT01599819, NCT01736475, NCT01913405, NCT01945593, NCT02210091, and NCT02585960 on Aug 7th '20.
To investigate its therapy, developer Baxalta (now part of Takeda ) had launched six clinical trials: NCT01599819, NCT01736475, NCT01913405, NCT01945593, NCT02210091, and NCT02585960.
Aug 07, 2020 | hemophilianewstoday.com
Baxalta Incorporated launched CUVITRU on Nov 1st '16.
For instance, in November 2016, Baxalta, a subsidiary of Shire launched CUVITRU, a subcutaneous immunoglobulin (Human), in the US for primary immunodeficiency.
Aug 05, 2020 | www.emailwire.com
Nektar Therapeutics partnered with Baxalta Incorporated on Dec 23rd '20.
Nektar had partnered with both Bayer and Baxalta on hemophilia in the 2000s, and "knew or should have known" about Bayer's patent despite licensing technology to Baxalta.
Feb 06, 2019 | www.fiercepharma.com

Baxalta's Email Address Formats

Baxalta uses at least 1 format(s):

Baxalta Email Formats	Example	Percentage
First.Last@baxalta.com	John.Doe@baxalta.com	96%
LastF@baxalta.com	DoeJ@baxalta.com	3%
FLast@baxalta.com	JDoe@baxalta.com	1%

Frequently Asked Questions

Where is Baxalta's headquarters located?

Baxalta's main headquarters is located at Northern Illinois, US. The company has employees across 6 continents, including North AmericaEuropeAsia.

What is Baxalta's phone number?

You can contact Baxalta's main corporate office by phone at

+1-888-237-****

. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Baxalta's stock symbol?

Baxalta is a publicly traded company; the company's stock symbol is BXLT.

What is Baxalta's official website and social media links?

Baxalta's official website is baxalta.com and has social profiles on LinkedIn.

How much revenue does Baxalta generate?

As of October 2024, Baxalta's annual revenue reached $1.6B.

What is Baxalta's SIC code NAICS code?

Baxalta's SIC code is 2836 - Biological Products, Except Diagnostic Substances NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Baxalta have currently?

As of October 2024, Baxalta has approximately 10K employees across 6 continents, including North AmericaEuropeAsia. Key team members include Chief Compliance Officer And Secretary: D. W.Chief Privacy Officer Assistant General Counsel: F. W.Vice President And Chief Compliance Officer: D. S.. Explore Baxalta's employee directory with LeadIQ.

What industry does Baxalta belong to?

Baxalta operates in the Biotechnology Research industry.

What is Baxalta's email format?

Baxalta's email format typically follows the pattern of . Find more Baxalta email formats with LeadIQ.

When was Baxalta founded?

Baxalta was founded in 2015.

Baxalta

Biotechnology ResearchIllinois, United States10001+ Employees

Shire acquired Baxalta on June 3, 2016. Following this date, this page will no longer be actively monitored. There will be no updates or responses posted on this page.  For continued news and updates, we encourage you to follow Shire on LinkedIn at https://www.linkedin.com/company/shire

Company Overview

Headquarters: Northern Illinois, US
Phone number: ✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
+1-888-237-****
Website: baxalta.com
SIC Code: 2836 - Biological Products, Except Diagnostic Substances
Stock Symbol: BXLT
NAICS Code: 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded: 2015
Employees: 10001+

Media & News

Funding & Financials

$1B
Baxalta's revenue is in the range of $1B

Funding & Financials

$1B
Baxalta's revenue is in the range of $1B

Company Leadership

D. W.
Chief Compliance Officer And Secretary
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
F. W.
Chief Privacy Officer Assistant General Counsel
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
D. S.
Vice President And Chief Compliance Officer
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. B.
Vice President Chief Technology Officer
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
A. Z.
Vice President Managed Markets Trade
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Employee Directory

F. V.
Founder; Managing Director; And Business Strategist; Coach
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. D.
Corporate Executive Assistant To The EVP And President, Hematology
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
J. N.
Senior Manager, External Quality Cmo
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
K. D.
Executive Assistant To President
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email
M. B.
Vice President Chief Technology Officer
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Mobile Phone
✕
Access Insights for Baxalta and Millions of Other Companies
Sign up for full access to Baxalta information.
No credit card needed
OR
Work email
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.
Email

Go to Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Baxalta

Werfen

Octapharma

Haemonetics

Grifols

CSL Behring

LFB

Baxalta Tech Stack

Media & News

The Shire merges with Baxalta Incorporated.

Takeda acquired Baxalta Incorporated on Jan 1st '19.

Baxalta Incorporated invests into assets: AAV8 vector.

Bayer AG files suit against Baxalta Incorporated.

Baxalta Incorporated launched six clinical trials: NCT01599819, NCT01736475, NCT01913405, NCT01945593, NCT02210091, and NCT02585960 on Aug 7th '20.

Baxalta Incorporated launched CUVITRU on Nov 1st '16.

Nektar Therapeutics partnered with Baxalta Incorporated on Dec 23rd '20.

Baxalta's Email Address Formats

Frequently Asked Questions

Where is Baxalta's headquarters located?

What is Baxalta's phone number?

What is Baxalta's stock symbol?

What is Baxalta's official website and social media links?

How much revenue does Baxalta generate?

What is Baxalta's SIC code NAICS code?

How many employees does Baxalta have currently?

What industry does Baxalta belong to?

What is Baxalta's email format?

When was Baxalta founded?

Baxalta

Company Overview

Media & News

The Shire merges with Baxalta Incorporated.

Takeda acquired Baxalta Incorporated on Jan 1st '19.

Baxalta Incorporated invests into assets: AAV8 vector.

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?